Monthly Archives: December 2018

Genprex to Launch Investors Website and Increase Emphasis on Investor Relations in 2019

AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 12, 2018-- Genprex, Inc. (NASDAQ: GNPX) a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it will be increasing its investor relations efforts in 2019.

Read More

Genprex to Present at the 11th Annual LD Micro Main Event

AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 3, 2018-- Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform

Read More